Artificial intelligence in brain tumor imaging: a step toward personalized medicine

M Cè, G Irmici, C Foschini, GM Danesini, LV Falsitta… - Current …, 2023‏ - mdpi.com
The application of artificial intelligence (AI) is accelerating the paradigm shift towards patient-
tailored brain tumor management, achieving optimal onco-functional balance for each …

Imaging of lymphomas involving the CNS: an update-review of the full spectrum of disease with an emphasis on the World Health Organization classifications of CNS …

A Pons-Escoda, P Naval-Baudin, R Velasco… - American Journal of …, 2023‏ - ajnr.org
Lymphomas of the CNS are the second most frequent primary brain malignancy in adults
after gliomas. Presurgical suspicion of lymphoma greatly impacts patient management. The …

Circulating tumor DNA profiling for detection, risk stratification, and classification of brain lymphomas

JA Mutter, SK Alig, MS Esfahani, EM Lauer… - Journal of Clinical …, 2023‏ - ascopubs.org
PURPOSE Clinical outcomes of patients with CNS lymphomas (CNSLs) are remarkably
heterogeneous, yet identification of patients at high risk for treatment failure is challenging …

Guidelines for the diagnosis and management of primary central nervous system diffuse large B‐cell lymphoma.

CP Fox, EH Phillips, J Smith, K Linton… - British journal of …, 2019‏ - search.ebscohost.com
The article offers guidelines for the diagnosis and management of primary central nervous
system diffuse large B-cell lymphoma. It informs on symptoms associated with the disease …

[HTML][HTML] Magnetic resonance spectroscopy—revisiting the biochemical and molecular milieu of brain tumors

A Verma, I Kumar, N Verma, P Aggarwal, R Ojha - BBA clinical, 2016‏ - Elsevier
Background Magnetic resonance spectroscopy (MRS) is an established tool for in-vivo
evaluation of the biochemical basis of human diseases. On one hand, such lucid depiction …

Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer …

S Jiang, H Yu, X Wang, S Lu, Y Li, L Feng, Y Zhang… - European …, 2016‏ - Springer
Objectives To show the ability of using the amide proton transfer-weighted (APTW) MRI
signals as imaging biomarkers to differentiate primary central nervous system lymphomas …

Lipid alterations in glioma: a systematic review

K Abdul Rashid, K Ibrahim, JHD Wong, N Mohd Ramli - Metabolites, 2022‏ - mdpi.com
Gliomas are highly lethal tumours characterised by heterogeneous molecular features,
producing various metabolic phenotypes leading to therapeutic resistance. Lipid metabolism …

Imaging features (CT, MRI, MRS, and PET/CT) of primary central nervous system lymphoma in immunocompetent patients

G Cheng, J Zhang - Neurological Sciences, 2019‏ - Springer
Background Because of the low incidence of primary central nervous system lymphoma
(PCNSL) in non-HIV individuals and because of the lack of specific clinical manifestations …

Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions

SS Lu, SJ Kim, HS Kim, CG Choi, YM Lim… - American Journal of …, 2014‏ - ajnr.org
BACKGROUND AND PURPOSE: It may be challenging to differentiate primary CNS
lymphomas, especially primary CNS lymphomas with atypical MR features, from tumefactive …

Patterns of response and relapse in primary CNS lymphomas after first-line chemotherapy: imaging analysis of the ANOCEF-GOELAMS prospective randomized trial

E Tabouret, C Houillier, N Martin-Duverneuil… - Neuro …, 2017‏ - academic.oup.com
Background. Our aim was to review MRI characteristics of patients with primary CNS
lymphoma (PCNSL) enrolled in a randomized phase II trial and to evaluate their potential …